COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Stephanie Smith, MD, MPH
- Telefonnummer: 209-609-0208
- E-post: smithsm@stanford.edu
Studiesteder
-
-
California
-
Palo Alto, California, Forente stater, 94304
- Rekruttering
- Stanford University
-
Ta kontakt med:
- Stephanie Smith, MD, MPH
- Telefonnummer: 209-609-0208
- E-post: smithsm@stanford.edu
-
Hovedetterforsker:
- Stephanie Smith, MD, MPH
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Childhood cancer survivor previously treated with chemotherapy and/or radiation therapy
- Currently age 18-25 years
- Identifies as Hispanic/Latino
- Currently ≥5 years post cancer diagnosis
- Fluent in English or Spanish
- Receives medical care at Stanford
- Lives within Jacob's Heart service area (zip codes within Monterey, Santa Cruz, Santa Clara, San Benito Counties: https://www.jacobsheart.org/service-area)
- Ability to understand and the willingness to provide written informed consent.
Exclusion Criteria:
1. Lack of proficiency in written and spoken English or Spanish
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Family-Centered Communication
Young Adult Cancer Survivors (YA-CCS)-support person dyads receive a family-centered communication intervention delivered by a community health worker and coordinated around a standard-of-care survivorship clinic visit. |
A novel family-centered communication intervention designed to facilitate communication among Young Adult Cancer Survivors (YA-CCS), their chosen support person, and clinicians through collaboration between the clinic and a community-based organization. The intervention includes pre-visit and post-visit sessions delivered by a community health worker and timed around a standard-of-care survivorship clinic visit. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of invited young adult cancer survivor-support person dyads enrolled
Tidsramme: From recruitment initiation through completion of study enrollment, up to 24 months
|
Feasibility assessed by the proportion of invited dyads who enroll in the study. |
From recruitment initiation through completion of study enrollment, up to 24 months
|
|
Proportion of enrolled young adult cancer survivors completing all intervention components
Tidsramme: From intervention initiation through intervention completion, up to 3 weeks
|
Feasibility assessed by the proportion of enrolled young adult cancer survivor participants who complete all intervention components. |
From intervention initiation through intervention completion, up to 3 weeks
|
|
Mean Theoretical Framework of Acceptability questionnaire score
Tidsramme: Post-intervention, within 2 months after intervention completion
|
Acceptability assessed using participant-reported Theoretical Framework of Acceptability (TFA) questionnaire scores. Scores range from 1-5, with higher scores indicating greater acceptability. |
Post-intervention, within 2 months after intervention completion
|
|
Mean Satisfaction With Visit Preparation questionnaire score
Tidsramme: Post-intervention, within 2 months after intervention completion
|
Acceptability assessed using participant-reported Satisfaction With Visit Preparation questionnaire scores. Scores range from -10 to 10, with higher scores indicating greater satisfaction. |
Post-intervention, within 2 months after intervention completion
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Stephanie Smith, MD, MPH, Stanford University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- IRB-85827
- 5K08CA285829 (U.S. NIH-stipend/kontrakt)
- NCI-2026-06570 (Registeridentifikator: National Cancer Institute Clinical Trials Reporting Program)
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .